MD, MHBA | Cardiologist at University Medical Center Hamburg-Eppendorf | Entrepreneur | Interested in Music & Sailing.
Hamburg, Deutschland
Joined March 2019
- Tweets231
- Following289
- Followers306
- Likes995
Julius Obergassel retweeted
Startschuss am @YoungDgk Stand!!
@sebFeickert @AndreasRillig @AGEP_DGK @danielsteven_ep @rhythm_lisa @VanessaSciacca_ @HenrikeHillmann
Doppelpack-Alarm🚨 am @youngdgk Stand!
Die @youngdgk hat wieder einen #Crashkurs EKG - kommt vorbei!
Anschließend, Publikationstipps von @phiso_de!
@kardiophil @franzi_koppe @laura_rottner @tichelbaecker
#DGK2024HT #DGKHerztage
Julius Obergassel retweeted
🚨Most excited about the results of our industry-independent DEDICATE trial presented by @MoritzSeiffert at #ACC24 and @NEJM, impressively demonstrating non-inferior safety of #TAVI versus #SAVR in lower risk patients. ❤️🩹@dzhk_germany @UCCS_HH @UKEHamburg
nejm.org/doi/full/10.1056/NE…
Julius Obergassel retweeted
Prophylactic VT ablation in RCT on 60 CTO patients. Significant reduction in time to first ICD therapy in this great study from Slovenja. Congrats! #EHRA2024
Julius Obergassel retweeted
🌍 Hello World! 🎉 Wir sind offiziell gegründet und unsere Mission beginnt jetzt! 🚀 Besucht uns auf unserer neuen Homepage 🌐: idmedizin.de! 👩⚕️👨⚕️
Julius Obergassel retweeted
Wir sind stolz, die Gründung der IDM bekannt zu geben! 🎉 Gemeinsam blicken wir einer spannenden Zukunft entgegen, in der wir digitalmedizinische Anwendungen im deutschen Gesundheitswesen vorantreiben werden. #DigitalHealth #Innovation #Gesundheitswesen #HealthTech
🌍 Hello World! 🎉 Wir sind offiziell gegründet und unsere Mission beginnt jetzt! 🚀 Besucht uns auf unserer neuen Homepage 🌐: idmedizin.de! 👩⚕️👨⚕️
Julius Obergassel retweeted
Very interesting summary…what you need to know about VT ablation endpoints! Ventricular Tachycardia Ablation Endpoints: Moving Beyond Noninducibility | JACC: Clinical Electrophysiology jacc.org/doi/10.1016/j.jacep… @Dr_Santangeli @Phiso_de
Julius Obergassel retweeted
💓💪🏻Anabolic steroid use can increase heart disease risk
Our study incl. clinical 🩺 and experimental 🧬 data now published @JPhysiol
Featured @unibirmingham:
birmingham.ac.uk/news/2024/a…
Find the full paper here:
doi.org/10.1113/JP284597
Super-resolution images waiting for you 🔬👀
Julius Obergassel retweeted
Excited to share our first-in-human experience with pulsed field mapping of ventricular tachycardia
Just published in JACC: Clinical Electrophysiology jacc.org/doi/10.1016/j.jacep…
@jskoruth @DMusikantow Keita Watanabe @iwanari65284818 Yury Malyshev @Abhishe34664456 @VivekReddyMD
Julius Obergassel retweeted
Elevated levels of biomarkers such as ANGPT2, BMP10, and NT-proBNP are linked to recurrent atrial fibrillation after a first AF ablation. Read more in Chua et al.'s latest Europace paper. academic.oup.com/europace/ar… #europace
Julius Obergassel retweeted
👉👉Now online! Our first experiences of commercial ablation procedures with #Affera and #Sphere9: effective, safe, time-efficient! Many thanks to our great EP team #UHZ_HamburgEppendorf and the #Medtronic team! The journey will go on!🙏💪
@AndreasRillig @AGEP_DGK @laura_rottner
Julius Obergassel retweeted
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation ahajournals.org/doi/10.1161/… @AGEP_DGK @YoungDgk
Julius Obergassel retweeted
Out now - our latest study on clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic #HeartFailure-related #CardiogenicShock. Grateful, great collaborative effort! @ESC_Journals #EJHF doi.org/10.1002/ejhf.3082
Julius Obergassel retweeted
Out now📊 Indicating a lower mortality risk with #MCS use only in patients with severely reduced #LVEF. Should we use #LVEF as an adjunctive parameter for MCS decision-making in non-ischaemic/HF-#CardiogenicShock? link.springer.com/article/10… @BenediktSchrage @dirkwestermann
Julius Obergassel retweeted
Still remembering the fantastic annual #H2020MAESTRIA meeting! Here is a snippet of our @ICVS_UoB and @UCCS_HH colleagues.
Thanks @CNIC_CARDIO for organising 💕
Julius Obergassel retweeted
Ein letztes #YoungDGKSelfie an unserem Stand auf den #DGKHerztage
@Hannah_Billig_ @Kardiophil @DennisLawin @bara_doc @Adem_AksoyMD @JObergassel @DjawidHashemi @DennisLawin @DocDerda @FSchindhelmMD @realdocdan @MAlZaidi_ @AnnaHohneck
Julius Obergassel retweeted
A nice chance to highlight the work led by the talented team of @joeltramo, @ShinoKany & @jpirruccello on pericardial adiposity.
Refreshed from the break, we now have @patrick_ellinor from @broadinstitute discussing work package 3 on multi-omics and focusing on pericardial adiposity
#H2020MAESTRIA
@afnet_ev
Julius Obergassel retweeted
This fantastic evening was followed by a coffee break before a visit to the royal theatre!
What a fantastic team ⭐️
#H2020Maestria
@afnet_ev
Julius Obergassel retweeted
Refreshed from the break, we now have @patrick_ellinor from @broadinstitute discussing work package 3 on multi-omics and focusing on pericardial adiposity
#H2020MAESTRIA
@afnet_ev
Julius Obergassel retweeted
Become an active part of the
🫀90th @DGK_org annual congress 2024.
👉Abstract submission starts today! 👈
❗️Deadline: 13th November 2023.❗️
Take this great opportunity!
@YoungDgk @DrV_Mann @AndreasRillig @danielsteven_ep
@AGIKinterv @GhanemAlexander @KardiologieHH
Julius Obergassel retweeted
Internationale Studie unter Leitung von #UKEHamburg und @uniklinik_hd: Katheterbehandlung auch bei schweren Schlaganfällen wirksam. Bei 18 Prozent der behandelten Patient:innen konnte der Tod oder eine Pflegebedürftigkeit verhindert werden. t1p.de/adg1u @TENSIONstudy